Brainsway Ltd
TASE:BWAY
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
937.1
2 026
|
Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Brainsway Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | IL |
Market Cap | 594m ILS |
Operating Margin |
-16%
|
Country | US |
Market Cap | 204.9B USD |
Operating Margin |
17%
|
Country | US |
Market Cap | 195.2B USD |
Operating Margin |
26%
|
Country | US |
Market Cap | 146.7B USD |
Operating Margin |
22%
|
Country | US |
Market Cap | 132.6B USD |
Operating Margin |
18%
|
Country | IE |
Market Cap | 110.6B USD |
Operating Margin |
19%
|
Country | US |
Market Cap | 64.7B USD |
Operating Margin |
14%
|
Country | DE |
Market Cap | 55.6B EUR |
Operating Margin |
12%
|
Country | CN |
Market Cap | 319.2B CNY |
Operating Margin |
37%
|
Country | US |
Market Cap | 41.6B USD |
Operating Margin |
28%
|
Country | US |
Market Cap | 37.7B USD |
Operating Margin |
13%
|
Brainsway Ltd
Glance View
Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Brainsway Ltd's most recent financial statements, the company has Operating Margin of -15.6%.